Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All human research was approved by the relevant institutional review boards for each study and conducted according to the Declaration of Helsinki. All participants provided written informed consent. The details per cohort are given in Supplemental Material Table 1 and below. AGES; European Ancestry; National Bioethics Committee in Iceland that acts as the institutional review board for the Icelandic Heart Association and by the National Institute on Aging Intramural Institutional Review Board. Iceland.; Approved. ASPS; European Ancestry; Medical University of Graz, Austria.; Approved. CARDIA; European Ancestry; Four Field Centers Institutions were part of CARDIA: 1 University of Alabama at Birmingham, Ala, 2 Northwestern University, Chicago, Ill., 3 University of Minnesota, Minneapolis, Minn., and 4 Kaiser Permanente Medical Care Program, Oakland, Calif. Institutional Review Board IRB approvals were obtained from each field center institution. Each subject signed an informed consent document. USA.; Approved. CARDIA; African American; Four Field Centers Institutions were part of CARDIA: 1 University of Alabama at Birmingham, Ala, 2 Northwestern University, Chicago, Ill., 3 University of Minnesota, Minneapolis, Minn., and 4 Kaiser Permanente Medical Care Program, Oakland, Calif. Institutional Review Board IRB approvals were obtained from each field center institution. Each subject signed an informed consent document. USA.; Approved. COPDGene; European Ancestry; Twenty one clinical study centers throughout the United States enrolled participants. Each study site obtained local Institutional Review Boards IRB approval to enroll participants and all subjects provide informed consent to participate in the study. A Certificate of Confidentiality from the US Department of Health and Human Services was obtained at the onset of the study to provide additional protection for the research participants and their subsequently generated data on genetic markers. The participating centers were: Ann Arbor VA, Ann Arbor, MI, Baylor College of Medicine, Houston, TX, Brigham and Women's Hospital, Boston, MA, Columbia University, New York, NY, Duke University Medical Center, Durham, NC, Fallon Clinic, Worcester, MA, Health Partners Research Foundation, Minneapolis, MN, Johns Hopkins University, Baltimore, MD, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Los Angeles, CA, Michael E. DeBakey VAMC, Houston, TX, Minneapolis VA, Minneapolis, MN, Morehouse School of Medicine, Atlanta, GA, National Jewish Health, Denver, CO, Temple University, Philadelphia, PA, University of Alabama, Birmingham, AL, University of California, San Diego, CA, University of Iowa, Iowa City, IA, University of Michigan, Ann Arbor, MI, University of Minnesota, Minneapolis, MN, University of Pittsburgh, Pittsburgh, PA, University of Texas Health Science Center at San Antonio, San Antonio, TX. USA.; Approved. COPDGene; African American; Twenty one clinical study centers throughout the United States enrolled participants. Each study site obtained local Institutional Review Boards IRB approval to enroll participants and all subjects provide informed consent to participate in the study. A Certificate of Confidentiality from the US Department of Health and Human Services was obtained at the onset of the study to provide additional protection for the research participants and their subsequently generated data on genetic markers. The participating centers were: Ann Arbor VA, Ann Arbor, MI, Baylor College of Medicine, Houston, TX, Brigham and Women's Hospital, Boston, MA, Columbia University, New York, NY, Duke University Medical Center, Durham, NC, Fallon Clinic, Worcester, MA, Health Partners Research Foundation, Minneapolis, MN, Johns Hopkins University, Baltimore, MD, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Los Angeles, CA, Michael E. DeBakey VAMC, Houston, TX, Minneapolis VA, Minneapolis, MN, Morehouse School of Medicine, Atlanta, GA, National Jewish Health, Denver, CO, Temple University, Philadelphia, PA, University of Alabama, Birmingham, AL, University of California, San Diego, CA, University of Iowa, Iowa City, IA, University of Michigan, Ann Arbor, MI, University of Minnesota, Minneapolis, MN, University of Pittsburgh, Pittsburgh, PA, University of Texas Health Science Center at San Antonio, San Antonio, TX. USA.; Approved. DHS; European Ancestry; Institutional Review Board at the Wake Forest University School of Medicine (WFUSM) and all participants gave written informed consent. Winston-Salem, NC, USA.; Approved. FamHS; European Ancestry; Washington University School of Medicine IRB. St. Louis, MO, USA.; Approved. FamHS; African American; Washington University School of Medicine IRB. St. Louis, MO, USA.; Approved. FHS; European Ancestry; Boston University IRB. Boston, MA, USA.; Approved. GENESTAR 1ea; European Ancestry; Johns Hopkins Medicine IRB. Baltimore, MD, USA.; Approved. GENESTAR 1aa; African American; Johns Hopkins Medicine IRB. Baltimore, MD, USA.; Approved. GENESTAR 2ea; European Ancestry; Johns Hopkins Medicine IRB. Baltimore, MD, USA.; Approved. GENESTAR 2aa; African American; Johns Hopkins Medicine IRB. Baltimore, MD, USA.; Approved. GENOA; European Ancestry; Mayo Clinic IRB. Rochester, MN, USA and University of Michigan IRB. Ann Arbor, MI, USA.; Approved. GENOA; African American; Mayo Clinic IRB, Rochester, MN, USA, University of Mississippi Medical Center IRB Jackson, MS, USA, and University of Michigan IRB. Ann Arbor, MI, USA.; Approved. JHS; African American; Jackson Heart Study Community Ethics Advisory Board. Jackson, MS, USA.; Approved. LLS; European Ancestry; Leiden University Medical Center Ethical Committee. The Netherlands; Approved. MESA; European Ancestry; IRBs from Columbia University, New York, Johns Hopkins University, Baltimore, Northwestern University, Chicago, UCLA, Los Angeles, University of Minnesota, Twin Cities, Wake Forest University, Winston Salem in the USA.; Approved. MESA; African American; IRBs from Columbia University, New York, Johns Hopkins University, Baltimore, Northwestern University, Chicago, UCLA, Los Angeles, University of Minnesota, Twin Cities, Wake Forest University, Winston Salem in the USA.; Approved. NELSON; European Ancestry; Dutch Minister of Health, and Ethical Committees from University Medical Center Groningen, University Medical Center Utrecht and Kennemer Gasthuis Haarlem in the Netherlands, and University Hospital Gasthuisberg Leuven in Belgium.; Approved. RS-I; European Ancestry; Medical Ethics Committee of the Erasmus MC and by the Dutch Ministry of Health, Welfare and Sport. Rotterdam, The Netherlands.; Approved. RS-II; European Ancestry; Medical Ethics Committee of the Erasmus MC and by the Dutch Ministry of Health, Welfare and Sport. Rotterdam, The Netherlands.; Approved. YFS; European Ancestry; Ethical Committee of Hospital District of Southwest Finland. Finland.; Approved.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes